Bank of New York Mellon Corp financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Bank of New York Mellon Corp files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue		15,543	16,392	16,462	15,808	15,931	16,529	17,697	18,619	20,080
Interest expense	437	1,074	2,821	4,360	1,132	227	3,614	16,303
Pre-tax income	3,147	2,699	3,008	3,516	2,698	2,965	1,849	2,196	3,462	4,431
Income tax	1,177	496	938	1,120	842	877	937	979	1,305	1,475
Net income to minority interests	1	24	-12	26	9	12	-13	2	13	34
Net income	3,547	4,090	4,266	4,441	3,617	3,759	2,556	3,302	4,530	5,549
EPS, basic	3.16	3.74	4.06	4.53	3.84	4.17	2.89	3.91	5.84	7.47
EPS, diluted	3.15	3.72	4.04	4.51	3.83	4.14	2.88	3.89	5.80	7.40
Shares, basic (weighted)	1,066	1,034	1,003	940	891	852	811	784	743	710
Shares, diluted (weighted)	1,072	1,040	1,007	943	893	856	815	788	748	717
Dividend per share	0.72	0.86	1.04	1.18	1.24	1.30	1.42	1.58	1.78	2.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	4,822	5,382	5,864	4,830	6,252	6,061	5,030	4,922	4,178	5,111
Property, plant and equipment					3,602	3,431	3,256	3,163	3,266	3,581
Lease right-of-use assets				1,530	1,432	1,250	1,152	1,125	1,076	1,126
Goodwill	17,316	17,564	17,350	17,386	17,496	17,512	16,150	16,261	16,598	16,767
Intangible assets	3,598	3,411	3,220	3,107	3,012	2,991	2,901	2,854	2,851	2,822
Total assets	333,469	371,758	362,873	381,508	469,633	444,438	405,560	409,877	416,064	472,300
Short-term debt					0	0		0	301	2,003
Total liabilities	293,889	330,012	322,005	339,780	423,513	401,047	364,933	368,972	374,300	427,492
Total debt	24,463	27,979	29,163	27,501	25,984	25,931	30,458	31,257	30,854	31,873
Paid-in capital	25,962	26,665	27,118	27,515	27,823	28,128	28,508	28,908	29,321	29,907
Retained earnings	22,621	25,635	28,652	31,894	34,241	36,667	37,743	39,549	42,537	46,396
Treasury stock	-9,562	-12,248	-15,517	-18,844	-19,833	-24,400	-24,524	-27,151	-30,241	-33,805
Other comprehensive income	-3,765	-2,357	-3,171	-2,638	-985	-2,213	-5,966	-4,893	-4,656	-3,035
Shareholders' equity	38,811	41,251	40,638	41,483	45,801	43,034	40,734	40,770	41,318	44,313
Minority interests	618	316	101	102	143	196	7	50	359	408
Total equity	39,429	41,567	40,739	41,585	45,944	43,126	40,620	40,820	41,677	44,721
Total liabilities and equity	333,469	371,758	362,873	381,508	469,633	444,438	405,783	409,877	416,064	472,300
Shares outstanding	1,047	1,013	960	901	887	804	808	759	718	688

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	3,548	4,114	4,254	4,467	3,626	3,771	2,543	3,304	4,543	5,583
Depreciation and amortization	1,502	1,474	1,339	1,315	1,630	1,867	1,778	1,887	1,803	1,852
Stock-based compensation								0	0	1
Deferred income tax	-126	133	-525	-69	-193	257	183	-383	-345	99
Cash from operations	6,267	4,667	5,996	96	5,038	2,838	15,068	5,912	687	6,730
Capital expenditures	-825	-1,197	-1,108	-1,210	-1,222	-1,215	-1,346	-1,220	-1,469	-1,553
Acquisitions	-42	0	0	0	0	-170	0	0
Purchases of investments	-27,470	-26,151	-32,404	-46,435	-68,430	-54,239	-32,336	-23,422	-43,621	-37,549
Sales and maturities of investments	8,826	9,129	7,716	11,444	13,316	13,545	14,990	11,229	6,812	11,094
Cash from investing	50,284	-32,705	3,299	-10,548	-78,455	19,672	19,874	-5,810	-9,479	-44,283
Debt issued	6,229	4,738	5,143	2,993	2,993	5,186	9,929	6,487	5,737	5,737
Debt repaid	-2,953	-1,046	-3,650	-5,250	-5,200	-4,650	-4,000	-6,059	-5,963	-5,509
Stock issued	27	34	40	21	12	13	14	16	17	19
Share buybacks	-2,398	-2,686	-3,269	-3,327	-989	-4,567	-124	-2,604	-3,064	-3,535
Dividends paid	-778	-901	-1,052	-1,120	-1,117	-1,126	-1,165	-1,262	-1,348	-1,447
Cash from financing	-59,050	26,778	-8,098	9,459	75,508	-21,962	-33,654	-3,519	6,338	39,714
Exchange rate effect	-114	189	-72	2	61	-84	358	230	-311	221
Net change in cash	-2,613	-1,071	1,125	-991	2,152	464	1,646	-3,187	-2,765	2,382
Free cash flow	5,442	3,470	4,888	-1,114	3,816	1,623	13,722	4,692	-782	5,177
Interest paid	406	1,033	2,711	4,400	1,236	233	3,307	16,021	21,374	20,629
Income taxes paid	1,010	498	983	989	1,341	473	449	865	1,200	991

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $150.15 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Return on equity (ROE)	14.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.2%	Net income / average total assets.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	7.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	6.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	22.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	29.5%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	8.9%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	27.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	37.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	14.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	879.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-23.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	6.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow CAGR, 3y	-27.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	6.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	12.4%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	12.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	10.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	7.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	2.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-0.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	13.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	5.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-4.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-4.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Debt / equity	0.68x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	5.8%	Total debt / total assets.
Liabilities / assets	91.4%	Total liabilities / total assets.
Net debt	$22.89B	Total debt - cash - short-term investments. Negative means more cash than debt.
Goodwill and intangibles / assets	3.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$25.13B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
FCF conversion	25.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	55.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$9.10	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
FCF per share	$2.30	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.16	Cash from operations / diluted weighted shares.
Book value per share	$64.52	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$36.31	Tangible book value / shares outstanding.
Cash per share	$10.81	(Cash + short-term investments) / shares outstanding.
Payout ratio	26.1%	Dividends paid / net income, when net income is positive.
Dividends / FCF	103.3%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	250.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$101.88B	Share price x shares outstanding.
Enterprise value	$124.76B	Market cap + total debt - cash - short-term investments.
P/E	16.2x	Market cap / net income. Only when net income is positive.
P/B	2.28x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	4.05x	Market cap / tangible book value, when positive.
P/FCF	64.0x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	28.5x	Market cap / cash from operations, when positive.
EV/FCF	78.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.6%	Free cash flow / market cap.
Earnings yield	6.2%	Net income / market cap (the inverse of P/E).
Dividend yield	1.6%	Dividends paid over the period / market cap.
Shareholder yield	5.5%	(Dividends paid + share buybacks) / market cap.
PEG	0.44x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Bank of New York Mellon Corp's revenue in fiscal 2025?

Bank of New York Mellon Corp reported revenue of $20.08B for fiscal 2025, 7.8% higher than the year before.

Was Bank of New York Mellon Corp profitable in fiscal 2025?

Yes. Net income was $5.55B, a net margin of 27.6%.

How much free cash flow did Bank of New York Mellon Corp generate in fiscal 2025?

Cash from operations of $6.73B minus capital expenditures of $1.55B left free cash flow of $5.18B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Bank of New York Mellon Corp